Guangdong Biolight Meditech Co Ltd (300246) - Total Assets

Latest as of September 2025: CN¥2.53 Billion CNY ≈ $369.92 Million USD

Based on the latest financial reports, Guangdong Biolight Meditech Co Ltd (300246) holds total assets worth CN¥2.53 Billion CNY (≈ $369.92 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Guangdong Biolight Meditech Co Ltd's book value for net asset value and shareholders' equity analysis.

Guangdong Biolight Meditech Co Ltd - Total Assets Trend (2008–2024)

This chart illustrates how Guangdong Biolight Meditech Co Ltd's total assets have evolved over time, based on quarterly financial data.

Guangdong Biolight Meditech Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Guangdong Biolight Meditech Co Ltd's total assets of CN¥2.53 Billion consist of 53.4% current assets and 46.6% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	18.7%
Accounts Receivable	CN¥293.90 Million	11.8%
Inventory	CN¥232.07 Million	9.3%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥114.41 Million	4.6%
Goodwill	CN¥25.15 Million	1.0%

Asset Composition Trend (2008–2024)

This chart illustrates how Guangdong Biolight Meditech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Guangdong Biolight Meditech Co Ltd (300246) market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Guangdong Biolight Meditech Co Ltd's current assets represent 53.4% of total assets in 2024, a decrease from 78.9% in 2008.
Cash Position: Cash and equivalents constituted 18.7% of total assets in 2024, up from 18.3% in 2008.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 1.0% in 2008.
Asset Diversification: The largest asset category is accounts receivable at 11.8% of total assets.

Guangdong Biolight Meditech Co Ltd Competitors by Total Assets

Key competitors of Guangdong Biolight Meditech Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Demant A/S CO:DEMANT	Denmark	Dkr39.07 Billion
Double Medical Technology Inc SHE:002901	China	CN¥4.55 Billion
Beijing Wandong Medical Technology Co Ltd SHG:600055	China	CN¥5.70 Billion
Sinocare Inc SHE:300298	China	CN¥6.25 Billion
MODULIGHT OY EO 1 F:78W	Germany	€49.14 Million
Diagnostic Medical Systems SA PA:ALDMS	France	€57.17 Million
Theradiag SA PA:ALTHE	France	€11.55 Million
Nova EYE Medical Ltd AU:EYE	Australia	AU$23.67 Million

Guangdong Biolight Meditech Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.62	1.99	2.20
Quick Ratio	1.26	1.64	1.82
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥491.71 Million	CN¥651.53 Million	CN¥471.81 Million

Guangdong Biolight Meditech Co Ltd - Advanced Valuation Insights

This section examines the relationship between Guangdong Biolight Meditech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.89
Latest Market Cap to Assets Ratio	0.27
Asset Growth Rate (YoY)	-1.4%
Total Assets	CN¥2.50 Billion
Market Capitalization	$685.28 Million USD

Valuation Analysis

Below Book Valuation: The market values Guangdong Biolight Meditech Co Ltd's assets below their book value (0.27x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Guangdong Biolight Meditech Co Ltd's assets decreased by 1.4% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Guangdong Biolight Meditech Co Ltd (2008–2024)

The table below shows the annual total assets of Guangdong Biolight Meditech Co Ltd from 2008 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥2.50 Billion ≈ $365.66 Million	-1.40%
2023-12-31	CN¥2.53 Billion ≈ $370.86 Million	+3.92%
2022-12-31	CN¥2.44 Billion ≈ $356.88 Million	+41.83%
2021-12-31	CN¥1.72 Billion ≈ $251.62 Million	+6.99%
2020-12-31	CN¥1.61 Billion ≈ $235.18 Million	+67.16%
2019-12-31	CN¥961.46 Million ≈ $140.69 Million	+4.72%
2018-12-31	CN¥918.15 Million ≈ $134.35 Million	+14.74%
2017-12-31	CN¥800.22 Million ≈ $117.10 Million	+16.55%
2016-12-31	CN¥686.57 Million ≈ $100.47 Million	+18.24%
2015-12-31	CN¥580.65 Million ≈ $84.97 Million	+11.88%
2014-12-31	CN¥519.01 Million ≈ $75.95 Million	+10.03%
2013-12-31	CN¥471.72 Million ≈ $69.03 Million	+8.82%
2012-12-31	CN¥433.50 Million ≈ $63.43 Million	+9.34%
2011-12-31	CN¥396.48 Million ≈ $58.02 Million	+209.73%
2010-12-31	CN¥128.01 Million ≈ $18.73 Million	+23.82%
2009-12-31	CN¥103.38 Million ≈ $15.13 Million	+31.86%
2008-12-31	CN¥78.41 Million ≈ $11.47 Million	--

About Guangdong Biolight Meditech Co Ltd

SHE:300246 China Medical Devices

Market Cap

$685.28 Million

CN¥4.68 Billion CNY

Market Cap Rank

#10953 Global

#3239 in China

Share Price

CN¥17.70

Change (1 day)

+4.06%

52-Week Range

CN¥7.29 - CN¥17.70

All Time High

CN¥30.12